The Respiratory System

 LUNGS – NORMAL STRUCTURE

Anatomy

  • Right lung: 375–550 g (avg. 450 g), 3 lobes (upper, middle, lower), 2 fissures.

  • Left lung: 325–450 g (avg. 400 g), 2 lobes (upper, lower), 1 fissure. Middle lobe represented by lingula.

  • Airway pathway:
    Trachea → Right/Left Main Bronchi → Segmental bronchi → Terminal bronchioles → Acinus (functional unit).

  • Acinus structure:

    1. Respiratory bronchioles (3–5 generations)

    2. Alveolar ducts

    3. Alveolar sacs (alveoli)

  • Pulmonary lobule: Cluster of 5 acini.

Airway Wall Composition

  • Trachea/bronchi: Cartilage, smooth muscle, mucous glands.

  • Bronchioles: Smooth muscle only; no cartilage/mucous glands.

Blood Supply

  • Dual supply:

    • Pulmonary arteries: Deoxygenated blood.

    • Bronchial arteries: Oxygenated blood.

  • Lymphatics: Subpleural plexus → Hilar/tracheobronchial nodes → Thoracic duct.


🧬 Histology

  • Bronchi/Bronchioles: Lined by pseudostratified ciliated columnar epithelium with goblet cells (decrease toward bronchioles).

  • Bronchioles: No goblet cells; have Clara cells (secrete lysozyme, Ig; no surfactant).

  • Alveolar wall (septum):

    1. Capillary endothelium

    2. Basement membrane + scant interstitium

    3. Alveolar epithelium:

      • Type I pneumocytes: 95%, gas exchange.

      • Type II pneumocytes: Microvilli, secrete surfactant, proliferate to replace Type I.

    4. Alveolar macrophages

    5. Pores of Kohn: Allow inter-alveolar communication (bacteria/exudate spread).


💨 Functions

  • Gas exchange (O₂ in, CO₂ out)

  • Clearance of inhaled pollutants via mucociliary action, macrophages, lymphatics

  • Pulmonary circulation affects and is affected by heart diseases.


PAEDIATRIC LUNG DISEASE

1. Congenital Cysts

  • Defects in bronchial cartilage, elastic tissue/muscle → cysts.

  • Large cyst = Pneumatocele

  • Multiple small cysts = Sponge-like lung appearance.

  • May rupture → pneumothorax or haemoptysis

2. Bronchopulmonary Sequestration

  • Lung tissue not connected to airways.

  • Blood supply: From aorta, not pulmonary arteries.

  • Types:

    • Intralobar: Within pleura.

    • Extralobar: Outside pleura, usually in infants, often with anomalies.


ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)

Also called Hyaline Membrane Disease (HMD)

Types

  • Neonatal ARDS

  • Adult ARDS (a.k.a. DAD – Diffuse Alveolar Damage)


🌬️ Clinical Features

  • Neonatal ARDS: Dyspnoea, cyanosis, rapid breathing post-birth; often fatal.

  • Adult ARDS: Sudden respiratory failure, cyanosis, stiff lungs, poor response to oxygen.


⚠️ Etiology

Neonatal ARDS:

  • Prematurity

  • Diabetic mothers

  • Caesarean delivery

  • Male > female

  • Birth asphyxia

  • Sedation

  • Idiopathic

Adult ARDS:

  • Shock (trauma, sepsis, burns)

  • Viral infections

  • Pancreatitis

  • Toxins, narcotics, radiation

  • Aspiration, fat embolism

  • Drugs (salicylates, colchicine)


🔬 Pathogenesis

Neonatal:

  • ↓ Surfactant (from Type II cells) → ↑ surface tension → Atelectasis

  • Leads to: ↓ ventilation/perfusion → Ischemia → Hyaline membrane formation

Adult:

  • Cytokine imbalance:

    • Pro-inflammatory: IL-1, IL-8, TNF

    • Neutrophils → Proteases, oxidants → Tissue damage

  • Repair phase: Fibrogenic cytokines (TGF-α, PDGF) → Fibrosis

  • End result: Alveolar/capillary injury → Oedema, hyaline membranes, stiff lungs


🧪 Morphology

Gross:

  • Lungs: Heavy, airless, sink in water

Microscopy:

  1. Collapsed + dilated alveoli

  2. Necrotic epithelium, eosinophilic hyaline membranes (fibrin + debris)

  3. Oedema, congestion, intra-alveolar haemorrhage

  4. May develop bronchopneumonia

  5. Type II pneumocyte proliferation

  6. Organising stage: Interstitial fibrosis


🧭 Consequences

  1. Death: High neonatal mortality (esp. <1kg); adult ARDS has poor prognosis

  2. Resolution: Possible with supportive care/ventilation

  3. Long-term sequelae:

    • Bronchopulmonary dysplasia (in neonates)

    • Desquamative interstitial pneumonia (DIP)

    • Fibrosing alveolitis (Hamman-Rich syndrome)


2. Bronchopulmonary Dysplasia (BPD)

  • Occurs in: Neonates treated for ARDS with oxygen + ventilation.

  • Cause: Oxygen toxicity + barotrauma.

  • Clinical: Persistent respiratory distress (3–6 months).

  • Microscopy:

    • Fibrous thickening of alveolar walls.

    • Bronchiolitis, peribronchial fibrosis, emphysema.

    • Squamous metaplasia in bronchioles.


3. Atelectasis & Pulmonary Collapse

Atelectasis:

  • Primary: Incomplete lung expansion in neonates (esp. stillborn).

  • Causes: Prematurity, birth injury, CNS defects, intrauterine hypoxia.

  • Lungs: Small, dark blue, non-crepitant.

  • Microscopy: Collapsed alveoli, proteinaceous fluid, epithelial squames, possible emphysema/pneumothorax.

Collapse (Secondary Atelectasis):

  • Occurs in: Previously expanded lungs.

  • Types:

    1. Compressive: Due to external pressure (e.g., pleural effusion, tumour).

    2. Obstructive/Absorptive: Airway block (e.g., mucus plug, tumour, foreign body).

    3. Contraction: Lung fibrosis leading to collapse.


4. Bronchiolitis & Bronchiolitis Obliterans

  • Age group: Older children & elderly.

  • Causes:

    • Viral (RSV, adenovirus), bacterial, fungal.

    • Inhalation (toxic gases), aspiration.

  • Microscopy:

    • Fibrous plugs in bronchioles.

    • Lymphoplasmacytic infiltration.

    • Interstitial pneumonitis & alveolar fibrosis.


5. Sudden Infant Death Syndrome (SIDS)

  • Also called: Crib death.

  • Age group: 2–6 months.

  • Risk factors: Prematurity, maternal smoking, drug abuse.

  • Autopsy: Petechial haemorrhages in lungs & airways.


6. Pulmonary Vascular Disease

Pulmonary Hypertension (PH)

  • Definition: Pulmonary arterial systolic BP >30 mmHg.

  • Types:

    • Primary (Idiopathic): Rare, mostly young females or children.

    • Secondary: More common, typically >50 years.

Primary Pulmonary Hypertension – Possible Causes:
  1. Chronic vasoconstriction.

  2. Thromboemboli/amniotic fluid embolism in pregnancy.

  3. Autoimmune (SLE, scleroderma, RA).

  4. Pulmonary veno-occlusive disease.

  5. Toxins (bush tea, contraceptives, aminorex).

  6. Genetic (familial cases).

Secondary Pulmonary Hypertension – Categories:

A. Passive (↑ pulmonary venous pressure):

  • Mitral stenosis, LV failure.

B. Hyperkinetic (↑ volume/pressure):

  • PDA, septal defects.

C. Vaso-occlusive (↓ vascular bed):

  • Obstructive: Emboli, sickle cell, schistosomiasis.

  • Obliterative: Emphysema, TB, bronchiectasis, pneumoconiosis.

  • Vasoconstrictive: High altitude, obesity, neuromuscular disease.

Morphology:
  • Heart: Right ventricular hypertrophy, right atrial dilation (cor pulmonale).

  • Vascular changes (affecting all arterial sizes):

    • Small arteries/arterioles: Medial hypertrophy, plexiform lesions.

    • Medium arteries: Intimal thickening, adventitial fibrosis.

    • Large arteries: Atherosclerosis.


PNEUMONIA – DEFINITION

  • Pneumonia is acute inflammation of the lung parenchyma distal to the terminal bronchioles (includes alveolar ducts, sacs, and alveoli).

  • Pneumonitis is another term used synonymously.

  • Consolidation: Solidification of lung tissue, seen grossly or radiologically in pneumonia.


PATHOGENESIS

Microorganisms enter the lungs through:

  1. Inhalation from the air.

  2. Aspiration from oropharynx/nasopharynx.

  3. Haematogenous spread (bloodstream).

  4. Direct spread from adjacent infection.


DEFENSE MECHANISMS OF LUNGS

  • Nasopharyngeal filtering

  • Mucociliary clearance

  • Alveolar macrophages

  • Immunoglobulins


PREDISPOSING FACTORS

  1. Altered consciousness (e.g. coma, trauma, seizures, alcoholism).

  2. Depressed cough reflex (e.g. post-surgery, neuromuscular disease).

  3. Impaired mucociliary transport (e.g. smoking, viral infections).

  4. Alveolar macrophage dysfunction (e.g. hypoxia, malnutrition).

  5. Endobronchial obstruction (e.g. tumor, foreign body).

  6. Leucocyte dysfunctions (e.g. AIDS, chemotherapy).


CLASSIFICATION OF PNEUMONIAS

Based on Anatomic Involvement

  1. Lobar Pneumonia

  2. Bronchopneumonia (Lobular pneumonia)

  3. Interstitial Pneumonia

Etiologic Classification (Table 17.1)

A. Bacterial Pneumonias

  • Lobar pneumonia

  • Bronchopneumonia

B. Viral and Mycoplasmal Pneumonias

  • Primary atypical pneumonia

C. Other Types

  • Pneumocystis pneumonia

  • Legionella (Legionnaire’s disease)

  • Aspiration pneumonia

  • Hypostatic pneumonia

  • Lipid pneumonia


A. BACTERIAL PNEUMONIA

1. LOBAR PNEUMONIA

Definition: Acute bacterial infection affecting part/whole of one or more lobes.

Common Pathogens:

  1. Streptococcus pneumoniae (90% of cases)

  2. Staphylococcus aureus

  3. β-hemolytic streptococci

  4. Klebsiella pneumoniae, Haemophilus influenzae, E. coli, Pseudomonas


Stages of Lobar Pneumonia (Laennec’s Stages)

1. Congestion (1–2 days)

  • Gross: Dark red, heavy, blood-stained frothy fluid

  • Microscopy: Dilated capillaries, oedema, few neutrophils, bacteria

2. Red Hepatisation (2–4 days)

  • Gross: Liver-like red, firm, airless lung

  • Microscopy: Fibrin, many neutrophils, red cells, engulfed bacteria

3. Grey Hepatisation (4–8 days)

  • Gross: Grey, firm, granular, dry cut surface

  • Microscopy: More fibrin, fewer neutrophils/RBCs, macrophages begin to appear

4. Resolution (after day 8–9 or early with antibiotics)

  • Gross: Frothy, grey-red fluid, softening from center

  • Microscopy: Macrophages predominant, removal of exudate, lung aeration restored


Complications of Lobar Pneumonia

  1. Organization → Fibrous lung (carnification)

  2. Pleural effusion → May resolve or form adhesions

  3. Empyema → Pus in pleural cavity

  4. Lung abscess

  5. Metastatic infection → Pericarditis, endocarditis, meningitis, brain abscess


Clinical Features

  • Sudden onset, chills, fever, pleuritic chest pain

  • Productive cough (mucoid/purulent/bloody)

  • Neutrophilic leucocytosis

  • X-ray: Lobar consolidation

  • Sputum culture guides treatment

  • Good response to antibiotics (within 48–72 hours)


2. BRONCHOPNEUMONIA (Lobular Pneumonia)

Definition: Patchy bacterial infection around terminal bronchioles and alveoli

Common in:

  • Infants & elderly

  • Post-viral infections (e.g. influenza, measles)

  • Bedridden, debilitated patients

Causative Organisms:

  • Staphylococci, Streptococci, Pneumococci

  • Klebsiella pneumoniae, Haemophilus influenzae, Pseudomonas


Morphology:

  • Gross: Patchy red/grey dry lesions (3–4 cm), lower zones, bilateral

  • Microscopy:

    • Acute bronchiolitis

    • Neutrophil-rich exudate in alveoli

    • Septal thickening, oedema in less affected areas


Complications:

  • Bronchiolar fibrosis → Bronchiectasis

  • Other complications similar to lobar pneumonia

Clinical Features:

  • History of prior illness or infection

  • Starts as bronchitis, progresses to pneumonia

  • Blood: Neutrophilic leucocytosis

  • X-ray: Patchy, mottled opacities in lower zones


Comparison Table – Lobar vs Bronchopneumonia

Feature Lobar Pneumonia Bronchopneumonia
Definition Involves entire or part of lobe Patchy infection of bronchioles & alveoli
Age Adults Infants & elderly
Predisposing factors Healthy individuals Chronic illness, viral infections
Common organisms Pneumococcus, Klebsiella Staph, Strep, H. influenzae
Pathology 4 classic stages Patchy consolidation
X-ray Consolidation Mottled opacities
Prognosis Good Variable, complications more likely
Complications Less common Bronchiectasis, others

B. VIRAL & MYCOPLASMAL PNEUMONIA (Primary Atypical Pneumonia)

Definition: Inflammation confined to interstitial tissue of lungs. No alveolar exudate.

Etiology:

  • RSV (common)

  • Mycoplasma pneumoniae

  • Influenza, adenovirus, rhinovirus, CMV, coxsackievirus

  • Psittacosis (Chlamydia), Q fever (Coxiella)


Morphologic Features

Gross:

  • Lungs: Heavy, congested, with patchy to diffuse consolidation

  • Frothy/bloody fluid on cut surface

  • Mild or absent pleural reaction

Microscopy:

  1. Interstitial inflammation: Thickened alveolar walls with mononuclear cells (lymphocytes, macrophages, plasma cells)

  2. Necrotising bronchiolitis

  3. Reactive hyperplasia: Multinucleate giant cells, syncytia, viral inclusions (esp. CMV)

  4. Alveolar changes: Oedema, fibrin, hyaline membrane (if severe or bacterial superinfection)


Complications

  • Superimposed bacterial infection

  • Severe cases: Interstitial fibrosis


Clinical Features

  • Starts with upper respiratory symptoms (cold, fever, headache, muscle aches)

  • Then dry, hacking cough with retrosternal burning

  • Blood: Neutrophilic leucocytosis

  • X-ray: Patchy/diffuse consolidation

  • Cold agglutinin titers ↑ in Mycoplasma and adenovirus

  • Difficult to isolate organism


C. Other Types of Pneumonias

This category includes infective pneumonias like Pneumocystis carinii and Legionella pneumonia, as well as non-infective types such as aspiration, hypostatic, and lipid pneumonia.


1. Pneumocystis carinii Pneumonia (PCP)

  • Cause: Pneumocystis carinii (now P. jirovecii) – a protozoan found widely in the environment.

  • Mode of transmission: Inhalation (opportunistic infection).

  • Affected groups:

    • Neonates

    • Immunosuppressed individuals (e.g. HIV/AIDS, chemotherapy, organ transplant, malnutrition, agammaglobulinemia).

    • Commonest infection in HIV/AIDS patients.

Morphologic Features:

  • Gross: Lungs are consolidated, dry, and gray.

  • Microscopy:

    1. Interstitial pneumonitis with mononuclear infiltrate in alveolar walls.

    2. Alveoli filled with pink frothy fluid containing organisms.

    3. GMS stain reveals:

      • Oval or crescentic cysts (~5 μm)

      • Tiny black dot-like trophozoites.

    4. No significant inflammatory exudate.

Clinical Features:

  • Rapid onset dyspnoea, tachycardia, cyanosis, non-productive cough.

  • Fatal in 1–2 weeks if untreated.

  • Chest X-ray: Diffuse alveolar and interstitial infiltrates.


2. Legionella Pneumonia (Legionnaire’s Disease)

  • Cause: Legionella pneumophila – Gram-negative bacillus.

  • Source: Contaminated water (e.g., cooling towers, drinking water).

  • Predisposing Factors: Immunodeficiency, corticosteroids, old age, smoking.

Morphologic Features:

  • Gross: Widespread bronchopneumonia, pleural effusion common.

  • Microscopy:

    1. Intra-alveolar exudate – early neutrophils, later macrophages.

    2. Septal epithelial hyperplasia and thrombosis.

    3. Organisms seen in macrophages (special stains, immunofluorescence).

Clinical Features:

  • Malaise, headache, myalgia → fever, chills, cough, tachypnea.

  • Bacteremia may lead to:

    • Abdominal pain, diarrhea, proteinuria, mild liver dysfunction.


3. Aspiration (Inhalation) Pneumonia

  • Cause: Inhalation of food, gastric contents, oropharyngeal material.

  • Risk Factors: Unconsciousness, intoxication, neurological disorders, tumors, infants, tracheoesophageal fistula.

Morphologic Types:

  1. Sterile Aspirate (e.g., gastric acid):

    • Chemical pneumonitis

    • Hemorrhagic edema, particles in bronchioles

    • Cyanosis, shock, bloody sputum

  2. Non-Sterile Aspirate:

    • Bronchopneumonia with necrosis and suppuration

    • Granulomas with foreign body giant cells


4. Hypostatic Pneumonia

  • Cause: Stagnation of fluid in basal/posterior lung parts in debilitated patients.

  • Common in: Bedridden, comatose, or elderly patients.

  • Mechanism: Accumulated fluid gets infected by URT flora → pneumonia.


5. Lipid Pneumonia

  • Two Types:

    1. Exogenous: Aspiration of oily materials (nasal drops, paraffin, oily vitamins).

    2. Endogenous: Tissue breakdown due to obstruction (cancer, TB, bronchiectasis).

Morphologic Features:

  • Gross: Right lung often affected; golden-yellow consolidated areas.

  • Microscopy:

    • Foamy macrophages in alveoli (lipid-filled)

    • Cholesterol clefts, granulomas with foreign body giant cells


Lung Abscess

  • Definition: Localized necrosis with suppuration of lung tissue.

Types:

  1. Primary: In normal lung; mostly due to aspiration.

  2. Secondary: Complication of other lung diseases or systemic infections.

Etiology:

  • Organisms: Streptococci, staphylococci, Gram-negative bacteria.

  • Sources:

    • Aspiration (infected material, food, necrotic tissue)

    • Preceding infections (e.g., TB, bronchiectasis)

    • Bronchial obstruction (tumor, foreign body)

    • Septic embolism

    • Others: infarcts, amoebiasis, trauma, direct spread

Morphologic Features:

  • Site: Right lung, lower part of upper lobe or apex of lower lobe.

  • Gross:

    • Single (primary) or multiple (secondary) cavities (mm to 5–6 cm)

    • Acute: ragged wall; Chronic: fibrous wall

  • Microscopy:

    • Suppurative exudate

    • Chronic inflammatory infiltrate

    • Fibrocollagenous wall in chronic abscess

Clinical Features:

  • Fever, malaise, weight loss, purulent sputum, hemoptysis

  • Clubbing (20%), secondary amyloidosis in chronic cases


Fungal Infections of Lung

More common than TB in the US; serious in immunocompromised.

1. Aspergillosis

  • Cause: Aspergillus fumigatus

  • Forms: Allergic bronchopulmonary aspergillosis, aspergilloma, necrotizing bronchitis

  • High risk: Leukemia, HIV/AIDS

  • Gross: Fungal ball in preexisting cavities

  • Microscopy:

    • Septate hyphae with acute angle branching

    • PAS and silver stain positive

    • Chronic inflammation in cavity wall

2. Mucormycosis

  • Cause: Mucor, Rhizopus

  • Seen in: Diabetic ketoacidosis

  • Features:

    • Broad, non-septate hyphae with obtuse branching

    • More destructive than aspergillosis

3. Candidiasis

  • Cause: Candida albicans

  • Commensal → pathogenic in immunosuppression

  • May invade blood vessels (angioinvasion)

4. Histoplasmosis

  • Cause: Histoplasma capsulatum (inhalation of bird droppings)

  • Lesions: Ghon’s complex-like

5. Cryptococcosis

  • Cause: Cryptococcus neoformans (pigeon droppings)

  • Lesions: Granuloma in lung, may cause meningitis

6. Coccidioidomycosis

  • Cause: Coccidioides immitis (contact with infected dogs)

  • Lesions: Peripheral granulomas

7. Blastomycosis

  • Cause: Blastomyces dermatitidis (inhaled spores)

  • Lesions: Ghon-like, pneumonia, skin nodules


📌 Fungal Pneumonias

1. Cryptococcosis

  • Cause: Cryptococcus neoformans (round yeast with a halo in tissues).

  • Source: Inhalation of pigeon droppings.

  • Lesions: Range from lung granuloma to cryptococcal meningitis.

2. Coccidioidomycosis

  • Cause: Coccidioides immitis (spherical spores).

  • Source: Close contact with infected dogs.

  • Lesion: Peripheral granuloma in the lung parenchyma.

3. Blastomycosis

  • Cause: Blastomyces dermatitidis.

  • Source: Inhalation of spores from soil.

  • Lesions:

    • Ghon’s complex-like lesion

    • Pneumonic consolidation

    • Multiple skin nodules


Pulmonary Tuberculosis (TB)

Type of Inflammation: Chronic Granulomatous Inflammation


1. Causative Agent

  • Mycobacterium tuberculosis (Koch’s bacillus)

  • Strict aerobe; thrives in oxygen-rich tissues (e.g., lung apex)

  • Human strains: M. tuberculosis hominis, M. bovis (rare), M. africanum, etc.


2. Morphology of Granuloma (Tubercle)

A fully-developed tubercle is ~1 mm in diameter and shows:

  • Central caseation necrosis (cheese-like)

  • Surrounding epithelioid cells

  • Langhans’ giant cells (20+ nuclei arranged peripherally)

  • Peripheral lymphocytes

  • Encapsulating fibroblasts and fibrosis


3. Cellular Components of TB Granuloma

  • Epithelioid cells: Modified macrophages; pale eosinophilic cytoplasm; weakly phagocytic.

  • Multinucleated giant cells: From fusion of epithelioid cells.

    • Langhans’ type (TB): nuclei in horseshoe/ring.

    • Foreign body type: central nuclei.

  • Lymphocytes: Cell-mediated immunity

  • Plasma cells: Humoral response

  • Necrosis: Central caseation

  • Fibrosis: Healing response


4. Diagnostic Methods

  • Ziehl-Neelsen stain: Acid-fast bacilli (AFB)

  • Culture: Lowenstein-Jensen medium (6 weeks)

  • PCR: Rapid, sensitive

  • Fluorescent stains

  • Guinea pig inoculation (historical)


5. Hypersensitivity & Immunity

  • Type IV hypersensitivity (cell-mediated)

  • Immune response due to cord factor & Wax-D

  • Tuberculin (Mantoux) test: PPD injection → ≥15mm induration in 72 hrs indicates previous exposure

  • Koch’s phenomenon: Demonstrates immune memory in reinfection


6. Evolution of Tubercle (Granuloma)

  1. Neutrophils arrive but fail

  2. Macrophages dominate

  3. T/B cells activated → CD4+ cells induce granuloma formation

  4. Epithelioid cells form, fuse into giant cells

  5. Lymphocytes + fibroblasts surround

  6. Caseation necrosis appears (7–14 days)

  7. Possible fate:

    • Liquefaction → cold abscess

    • Sinus formation

    • Coalescence → fibrosis

    • Calcification or ossification


7. Types of Tuberculosis

A. Primary Tuberculosis (Ghon’s Complex)

  • Occurs in non-sensitized individuals

  • Common in children

  • Three components:

    1. Ghon’s focus: Subpleural lesion (lung)

    2. Draining lymphatics: Show tubercles

    3. Hilar lymphadenopathy: Caseation

  • Fate:

    • Healing → fibrosis/calcification

    • Progression → active spread or miliary TB

    • Reactivation → secondary TB

B. Secondary Tuberculosis (Reactivation or Reinfection)

  • In previously sensitized individuals

  • Often in lung apex (high O₂)

  • Lesions: Caseating granulomas with peripheral fibrosis

  • Can arise from:

    • Reactivation of dormant focus

    • Fresh exogenous infection


8. Spread of Tuberculosis

  1. Local: Macrophage migration

  2. Lymphatic: Regional lymph nodes

  3. Haematogenous: Miliary TB (liver, spleen, kidney, brain)

  4. Natural passages:

    • Pleura → pleurisy

    • Larynx → laryngitis

    • GI tract → ileocaecal TB

    • Kidney → bladder


9. Atypical Mycobacteria (Non-Tuberculous Mycobacteria)

  • Environmental mycobacteria; acid-fast

  • Include: M. avium, M. kansasii, M. fortuitum, M. ulcerans

  • Less virulent, not spread person-to-person

  • Classified as:

    • Rapid growers: M. fortuitum, M. chelonae

    • Slow growers:

      • Photochromogens: Pigment in light

      • Scotochromogens: Pigment in light/dark

      • Non-chromogens: No pigment


10. HIV-Associated Tuberculosis

  • High incidence in HIV/AIDS patients

  • Presents with sputum smear-negative but culture-positive TB

  • More extrapulmonary involvement: Lymph nodes, pleura, meninges

  • Also prone to M. avium-intracellulare infection


11. Key Examples of Granulomatous Inflammation

Condition Agent Feature
TB M. tuberculosis Caseating granuloma
Leprosy M. leprae Foamy histiocytes, granulomas
Sarcoidosis Unknown Non-caseating granulomas
Fungal infections Cryptococcus, Blastomyces Granulomas with yeast/fungi
Foreign body Talc, suture Foreign body granulomas

📌 Chronic Obstructive Pulmonary Disease (COPD)

Definition:

Group of chronic lung diseases with obstructed airflow at various levels, resulting in lung function disability.

Major Types:

  1. Chronic bronchitis

  2. Emphysema

  3. Bronchial asthma

  4. Bronchiectasis


📌 Chronic Bronchitis

Definition:

Persistent cough with expectoration for ≥ 3 months/year for 2 consecutive years.

Etiopathogenesis:

  1. Smoking (most common):

    • ↓ Ciliary activity

    • ↓ Alveolar macrophage function

    • ↑ Mucus glands (hypertrophy, hyperplasia)

    • ↑ Bronchial obstruction & bronchoconstriction

  2. Air Pollution: Sulfur dioxide, nitrogen dioxide, dust, fumes.

  3. Occupation: Exposure to dust in cotton mills, plastics.

  4. Infection: Secondary bacterial or viral infections.

  5. Genetics/Familial Factors: May contribute, especially via passive smoking.

Morphologic Features:

  • Gross: Thickened, oedematous bronchial walls with mucus plugs.

  • Microscopic:

    • Reid Index (submucosal gland thickness to total wall)

    • Squamous metaplasia, goblet cell hyperplasia

    • Mucus plugging, mild chronic inflammation

Clinical Features:

  • Persistent productive cough

  • Recurrent infections

  • Dyspnoea on exertion

  • "Blue Bloaters": Cyanosis, edema, right heart failure (cor pulmonale)

  • CXR: Enlarged heart, prominent vessels


📌 Emphysema

Definition (WHO):

  • Permanent dilatation of distal airspaces

  • Destruction of alveolar walls

  • Clinically and pathologically distinct from chronic bronchitis

Types (True Emphysema):

  1. Centriacinar (Centrilobular)

  2. Panacinar (Panlobular)

  3. Paraseptal (Distal Acinar)

  4. Irregular (Para-cicatricial)

  5. Mixed (Unclassified)

Overinflation Types:

  1. Compensatory overinflation

  2. Senile hyperinflation

  3. Obstructive overinflation (e.g. infantile lobar)

  4. Unilateral translucent lung

  5. Interstitial (Surgical) emphysema


📌 Etiopathogenesis of Emphysema

Protease-Antiprotease Hypothesis:

  • α1-antitrypsin (α1-AT) inhibits neutrophil elastase

  • In α1-AT deficiency (especially PiZZ genotype):

    • Loss of elastase inhibition → alveolar destruction

    • Associated with emphysema + liver cirrhosis

  • Smoking contributes by:

    • Inactivating α1-AT

    • ↑ Neutrophil elastase production


📌 Pathologic Features of Emphysema

Gross:

  • Overinflated, pale lungs

  • Rounded edges

  • Subpleural bullae and blebs

Microscopic:

  • Dilated airspaces

  • Destroyed septal walls

  • Loss of elastic tissue

  • Inflammatory changes vary by type


📌 Clinical Features of Predominant Emphysema

  • Long history of progressive dyspnoea

  • Use of accessory muscles

  • Barrel-shaped chest

  • Late-onset cough with scanty sputum

  • "Pink Puffers": well oxygenated, tachypnoeic

  • Weight loss common

  • Late-stage: Cor pulmonale, respiratory failure

  • CXR: Small heart, hyperinflated lungs


📌 Comparison: Predominant Bronchitis vs. Emphysema

Feature Predominant Bronchitis Predominant Emphysema
Age at diagnosis ~50 years ~60 years
Pathology Mucus gland hypertrophy Alveolar wall destruction
Dyspnoea Late, mild Early, severe
Cough Early Late
Sputum Copious, purulent Scanty, mucoid
Infections Frequent Rare
Cyanosis Common ("blue bloaters") Rare ("pink puffers")
Heart failure Common Terminal stage
CXR findings Large heart, prominent vessels Small heart, hyperinflated lungs

📌 Types of Emphysema: Morphology

  1. Centriacinar:

    • Central respiratory bronchioles affected

    • Upper lobes

    • Associated with smoking, coal workers

  2. Panacinar:

    • Whole acinus involved

    • Lower lobes

    • Associated with α1-AT deficiency

  3. Paraseptal:

    • Distal acinus affected

    • Subpleural region

    • Common cause of spontaneous pneumothorax

  4. Irregular:

    • Scarring around healed lesions

    • Often asymptomatic

  5. Mixed:

    • Combination of above types in elderly smokers


📌 Types of Overinflation

Type Description Cause
Compensatory Enlargement of remaining lung after surgery Post-lobectomy
Senile Aging-related lung dilation Elastic tissue loss
Obstructive Air trapping due to obstruction Foreign body, tumor
Unilateral One-sided translucent lung Childhood bronchiolitis
Interstitial Air in lung connective tissue Alveolar rupture, trauma, surgery

1. Interstitial Emphysema (Surgical Emphysema)

  • Definition: Entry of air into connective tissue framework of lung.

  • Causes:

    • Violent coughing (e.g., whooping cough, bronchitis)

    • Rupture of esophagus or trauma to lung/trachea

    • Air entry during surgery

    • Fractured ribs puncturing lung

    • Sudden pressure changes (e.g., decompression sickness)

  • Pathology:

    • Air leaks from ruptured alveoli to connective tissues → mediastinum, pleura, subcutaneous tissue

    • Can lead to pneumothorax

  • Histology:

    • Alveoli distended; septa intact

    • Not true emphysema

    • Clear air spaces in connective tissue


2. Bronchial Asthma

  • Definition: Hyperresponsive airways leading to reversible airway narrowing

  • Symptoms: Dyspnoea, cough, wheezing

  • Severe form: Status asthmaticus (may be fatal)

  • Epidemiology:

    • ~4% in US

    • 50% cases begin before age 10

Types of Asthma

Feature Extrinsic (Atopic/Allergic) Intrinsic (Non-atopic)
Age Childhood Adult
Allergy History Present Absent
Allergens Present Absent
Serum IgE Elevated Normal
Nasal polyps/Chronic bronchitis Absent Present
Drug Sensitivity Rare Often (e.g. Aspirin)

Pathogenesis

  • Extrinsic Asthma:

    • IgE-mediated Type I hypersensitivity

    • Triggered by allergens (e.g., dust, pollen)

    • Acute Phase: Mast cells → histamine, leukotrienes → bronchospasm, edema, mucus

    • Late Phase: Eosinophils, neutrophils → prolonged inflammation

  • Intrinsic Asthma:

    • Triggered by infections (esp. viral), cold, stress, drugs (e.g., aspirin)

    • No IgE involvement

  • Mixed Type: Overlapping features

Morphology

  • Gross: Overinflated lungs, mucus plug occlusion

  • Microscopy:

    1. Curschmann’s spirals: Twisted mucus with epithelium

    2. Charcot-Leyden crystals: Eosinophil-derived crystals

    3. Thickened basement membrane

    4. Submucosal gland & smooth muscle hypertrophy

    5. Inflammatory infiltrates (eosinophils, lymphocytes)

Clinical Features

  • Paroxysms of dyspnoea, wheezing, and cough

  • Eosinophilia in blood and sputum

  • Chronic asthma may lead to cor pulmonale


3. Bronchiectasis

  • Definition: Irreversible dilation of bronchi/bronchioles (>2 mm)

  • Symptoms: Persistent cough with foul-smelling, purulent sputum, haemoptysis, recurrent pneumonia

Etiology & Pathogenesis

  • Two major mechanisms:

    • Obstruction: Tumors, foreign bodies, lymph node compression

    • Infection: Often secondary to obstruction or severe necrotizing pneumonia

Associated Conditions:

  1. Congenital/Hereditary:

    • Congenital bronchiectasis

    • Cystic fibrosis

    • Immotile cilia syndrome (e.g., Kartagener’s syndrome)

  2. Obstructive causes:

    • Tumors, foreign body, TB scarring

  3. Secondary to infections:

    • Staphylococcal pneumonia, TB

Morphology

  • Gross:

    • Lower lobes commonly affected

    • Dilated bronchi reaching pleura; types: cylindrical, fusiform, saccular, varicose

    • Honeycomb lung appearance

  • Microscopy:

    • Ulceration or squamous metaplasia of epithelium

    • Inflammatory infiltrates

    • Destruction of smooth muscle and elastic tissue

    • Surrounding lung: fibrosis, interstitial pneumonia

Clinical Features

  • Chronic cough with copious foul sputum

  • Haemoptysis, recurrent infections

  • Complications: Clubbing, brain abscess, amyloidosis, cor pulmonale


4. Chronic Restrictive Pulmonary Disease

  • Definition: Reduced lung expansion, decreased total lung capacity

Types:

A. Chest Wall Disorders:

  • Kyphoscoliosis, poliomyelitis, severe obesity, pleural disease

B. Interstitial Lung Diseases (ILDs):

  • 200 types with common clinical/radiologic features

  • Affects alveoli, interstitium, capillaries

Pathogenesis:

  1. Initial inflammation (alveolitis) → neutrophil recruitment

  2. Type I pneumocyte damage → Type II cell proliferation

  3. Progressive fibrosishoneycomb lung

Clinical Features:

  • Exertional dyspnoea, dry cough, tachypnoea, cyanosis

  • No wheezing


5. Pneumoconioses

  • Definition: Lung diseases due to inhalation of dust (mostly occupational)

Important Factors:

  • Particle size (<1 μm most harmful)

  • Solubility, amount, host clearance capacity

  • Associated smoking

Types of Responses:

  1. Fibrous nodules (e.g., coal dust, silica)

  2. Interstitial fibrosis (e.g., asbestosis)

  3. Hypersensitivity reaction (e.g., beryllium)

Types of Pneumoconioses:

Agent Diseases
Coal Dust Simple CWP, Progressive Massive Fibrosis, Caplan’s syndrome
Silica Silicosis, Caplan’s syndrome
Asbestos Asbestosis, Mesothelioma
Organic Dusts Farmer’s lung, Bagassosis, Bird-fancier’s lung

Coal Workers’ Pneumoconiosis (CWP)

  • Most common form

  • Seen in coal miners after prolonged exposure (20–30 years)

  • Anthracosis: Benign, asymptomatic carbon accumulation

Stages:

  1. Simple CWP:

    • <5 mm coal macules

    • Mostly upper lobes

    • No alveolar wall destruction

  2. Progressive Massive Fibrosis (PMF):

    • 2 cm fibrotic black masses

    • Bilateral, upper zones

    • May cavitate due to TB or necrosis

  3. Caplan’s Syndrome:

    • CWP + rheumatoid nodules in lungs

Pathogenesis:

  • Macrophage ingestion of dust → inflammation & fibrosis via:

    • Free radicals

    • Cytokines (IL-1, TNF, PDGF)

    • Fibroblast proliferation

Microscopy:

  • Macrophages filled with carbon

  • Reticulin & collagen increase

  • Fibrotic nodules with dense collagen in PMF


Silicosis

Definition:

  • Silicosis is a chronic lung disease caused by long-term inhalation of crystalline silica dust.

  • Historically known as “knife grinders’ lung.”


Occupational Exposure:

  • High-risk jobs: Miners (granite, sandstone, coal, tin, copper), quarry workers, sandblasters, foundry workers, ceramic and slate/pencil/agate grinders.

  • In India: ~3 million workers are at risk, especially in construction and agate industries.


Forms:

  • Chronic Silicosis: Most common, associated with collagenous nodules.

  • Accelerated Silicosis: Acute form resembling alveolar proteinosis, showing irregular fibrosis and lipoproteinaceous exudate.


Pathogenesis:

  1. Inhaled silica particles (0.5–5 μm) reach alveoli → phagocytosed by alveolar macrophages → macrophage necrosis.

  2. Repetitive cycle of phagocytosis → necrosis.

  3. Dust transported to lymphatics and lymph nodes → induces immune cell aggregation (T/B lymphocytes, fibroblasts).

  4. Quartz (crystalline silica) is highly fibrogenic.

  5. Macrophage death triggers release of IL-1 and growth factors → fibroblast proliferation → collagen deposition.


Morphologic Features:

Gross:

  • Hard, fibrotic nodules (1–5 mm) in upper lobes.

  • May co-contain coal dust.

  • Pleura thickened and adherent; egg-shell calcifications visible on X-ray.

  • Possible complications: TB, Caplan’s syndrome (rheumatoid pneumoconiosis), cavitation.

Microscopy:

  1. Silicotic nodules near respiratory bronchioles, pleura, and lymph nodes.

  2. Nodules show central hyalinization, concentric collagen lamellae, dust-laden macrophages.

  3. Birefringent silica particles visible under polarizing microscope.

  4. Coalescence of nodules → progressive massive fibrosis.

  5. Intervening lung shows emphysema.

  6. Cavities: due to ischemic necrosis or TB/RA involvement.


Clinical Features:

  • Slow onset with dyspnoea and cough.

  • May show obstructive or restrictive lung disease pattern.

  • Common complications: TB, Caplan’s syndrome, cor pulmonale.

  • Radiology: Fine to coarse nodularity, egg-shell calcification.

  • No increased risk of bronchogenic carcinoma.


Asbestosis

Forms of Disease:

  1. Asbestosis (lung fibrosis)

  2. Pleural lesions (effusion, plaques, fibrosis)

  3. Tumors (bronchogenic carcinoma, mesothelioma)

Important Forms of Asbestos:

  • Chrysotile (serpentine) – flexible, common

  • Crocidolite, Amosite (amphibole) – rigid, more carcinogenic

Microscopy:

  • Interstitial fibrosis, asbestos bodies (beaded/dumbbell-shaped).

  • Pleural plaques: hyalinized, may calcify.

  • Tumors: ↑ risk of bronchogenic carcinoma, mesothelioma.


Berylliosis

Types:

  1. Acute – Exudative pneumonitis, resolves with removal of exposure.

  2. ChronicNon-caseating granulomas (like sarcoidosis), often 20+ years after exposure.

Histology:

  • Granulomas with birefringent crystals, Schaumann bodies, and asteroid bodies.


Hypersensitivity Pneumonitis (Allergic Alveolitis)

Etiology:

  • Inhalation of organic antigens: thermophilic actinomycetes (hay, sugarcane), bird proteins, barley, moldy wood, etc.

Examples:

  • Farmer’s lung, Bird-fancier’s lung, Bagassosis, Mushroom worker’s lung, Silo-filler’s disease.

Pathology:

  • Type III (immune complex) or Type IV (delayed hypersensitivity).

  • Alveolar wall inflammation, granulomas in early stage; fibrosis and honeycombing in chronic cases.


Pulmonary Infiltrates with Eosinophilia (PIE Syndrome)

Causes:

  1. Löffler’s syndrome – transient shadows, mild symptoms.

  2. Tropical eosinophilia – due to helminths (filaria, ascaris).

  3. Chronic eosinophilia – drugs, fungi, asthma.

  4. Idiopathic eosinophilic pneumonia

  5. Hypereosinophilic syndrome

Microscopy:

  • Alveolar walls and lumina filled with eosinophils, lymphocytes, granulomas possible.


Goodpasture’s Syndrome

Definition:

  • Autoimmune condition with pulmonary haemorrhage + rapidly progressive glomerulonephritis.

Pathogenesis:

  • Anti-GBM antibodies targeting shared antigen in lung and kidney basement membrane.

Microscopy:

  • Haemorrhage, necrosis, later fibrosis and haemosiderin-laden macrophages.

Clinical:

  • Young males, haemoptysis, anaemia, respiratory failure → later renal failure.


Pulmonary Alveolar Proteinosis

Definition:

  • PAS-positive, lipid-rich material fills alveoli.

Etiology:

  • May relate to silica, hematologic malignancies, macrophage dysfunction.

Histology:

  • Homogenous granular eosinophilic material, cholesterol clefts, minimal inflammation.


Tumours of the Lungs

I. Overview

  • Lungs can be affected by both benign and malignant tumours.

  • Bronchogenic carcinoma accounts for 95% of all primary lung tumours.

  • The lungs are also the most common site for metastases from other cancers.


II. WHO Classification of Lung Tumours

A. Epithelial Tumours

  • Benign: Papilloma, Adenoma

  • Dysplasia & Carcinoma in Situ

  • Malignant (Bronchogenic carcinoma):

    1. Squamous cell carcinoma

    2. Small cell carcinoma (oat cell, intermediate, combined)

    3. Adenocarcinoma (acinar, papillary, bronchioloalveolar, solid with mucus)

    4. Large cell carcinoma

    5. Adenosquamous carcinoma

  • Other Carcinomas:

    • Pulmonary neuroendocrine tumour (carcinoid)

    • Bronchial gland carcinomas (adenoid cystic, mucoepidermoid)

B. Soft Tissue Tumours

  • Fibroma, leiomyoma, lipoma, haemangioma, etc.

C. Pleural Tumours

  • Benign & malignant mesothelioma

D. Miscellaneous

  • Carcinosarcoma, pulmonary blastoma, melanoma, lymphoma

E. Secondary Tumours

  • Metastatic cancers from other sites


III. Bronchogenic Carcinoma

A. Incidence & Classification

  • Most common cancer in men and leading cause of cancer deaths.

  • Peak incidence: 55–65 years.

  • 5 Main Histologic Types:

    1. Squamous cell carcinoma

    2. Small cell carcinoma

    3. Adenocarcinoma (now most common subtype)

    4. Large cell carcinoma

    5. Adenosquamous carcinoma

  • Therapeutic Classification:

    • Small Cell Carcinoma (SCC): 20–25%

    • Non-Small Cell Carcinoma (NSCC): 70–75%

      • Includes squamous, adeno-, large cell

    • Combined Patterns: 5–10%


IV. Etiology

1. Smoking (Most important factor)

  • 80% of lung cancers occur in smokers.

  • Dose-dependent risk: 60–70x risk in heavy smokers

  • Cessation reduces but never eliminates risk.

  • Strongest link: Squamous & Small Cell types

  • Carcinogens in smoke: Polycyclic hydrocarbons, nitrosamines

2. Other Risk Factors

  • Air pollution

  • Occupational exposure (asbestos, uranium, nickel, beryllium, arsenic)

  • Vitamin A deficiency

  • Chronic scarring (TB, fibrosis, infarcts)


V. Molecular Pathogenesis

  1. Oncogene Activation:

    • K-RAS, EGFR, BRAF, MYC, PIK3CA

  2. Tumour Suppressor Gene Inactivation:

    • p53, Rb, p16, RASSF1A (on chromosome 3p)

  3. Autocrine Factors & Nicotine:

    • Nicotine promotes tumour growth via acetylcholine receptors.

  4. Inherited Risk:

    • Li-Fraumeni syndrome (p53), Retinoblastoma (Rb), family history

  5. Molecular Therapy Targets:

    • EGFR mutations → EGFR-TKI

    • VEGF overexpression → Anti-VEGF therapy

    • Proteomic signatures for future personalized diagnosis


VI. Morphologic Types

A. Gross Types

  1. Hilar Tumours (Central):

    • Arise in main/segmental bronchi

    • Grey-white friable mass

    • Commonly causes obstruction, cavitation

  2. Peripheral Tumours:

    • Commonly adenocarcinomas

    • Often located near lung periphery, appear mucoid

B. Histologic Types

  1. Squamous Cell Carcinoma:

    • Arises in large bronchi

    • Strong link with smoking

    • Shows keratinization or intercellular bridges

    • May show spindle cell variant

  2. Small Cell Carcinoma:

    • Central location, highly malignant

    • Shows neuroendocrine markers (Chromogranin, NSE)

    • 3 Subtypes:

      • Oat cell

      • Intermediate cell

      • Combined

  3. Adenocarcinoma:

    • Most common in women and non-smokers

    • Types:

      • Acinar

      • Papillary

      • Bronchioloalveolar (grows along alveoli)

      • Solid (with mucin vacuoles)

  4. Large Cell Carcinoma:

    • Undifferentiated, aggressive

    • Large nuclei, abundant cytoplasm

  5. Adenosquamous Carcinoma:

    • Features of both squamous & adenocarcinoma

    • Often peripheral, scar-related


VII. Spread

  1. Direct Invasion:

    • Bronchus → Pleura → Pericardium → Great vessels

    • Pancoast tumour: Apical lung cancer → brachial plexus, sympathetic chain

  2. Lymphatic Spread:

    • Hilar → Mediastinal → Supraclavicular nodes

  3. Haematogenous Spread:

    • Liver > Adrenals > Bones > Brain > Other organs


VIII. Clinical Features

  1. Local Symptoms:

    • Cough, chest pain, haemoptysis, dyspnoea

  2. Bronchial Obstruction:

    • Leads to pneumonia, abscess, bronchiectasis

  3. Metastatic Symptoms:

    • Bone pain, SVC syndrome, neurologic signs

  4. Paraneoplastic Syndromes:

    • Ectopic hormone production:

      • ACTH → Cushing’s

      • ADH → Hyponatraemia

      • PTH → Hypercalcaemia

      • Calcitonin → Hypocalcaemia

      • Gonadotropins → Gynaecomastia

    • Others:

      • Clubbing, osteoarthropathy

      • Polymyositis, neuropathies

      • Thrombophlebitis, coagulopathies


IX. Differential Diagnosis of Haemoptysis

  1. Infectious: TB, abscess, pneumonia, bronchiectasis

  2. Neoplastic: Lung cancer, bronchial adenoma

  3. Others: PE, LV failure, mitral stenosis, trauma, PPH


X. TNM Staging & Prognosis

  • Occult: Malignant cells only

  • Stage I: Tumour < 3 cm, no distant spread

  • Stage II: Tumour > 3 cm, ipsilateral node involvement

  • Stage III: Invasion of structures or distant spread

Prognosis

  • 5-year survival: ~15%

  • Best prognosis: Adenocarcinoma & Squamous Cell (if localized)

  • Worst prognosis: Small Cell (highly aggressive, metastatic early)


HAMARTOMA

  • Definition: A benign, tumor-like lesion made of disorganized but mature lung tissue elements.

  • Incidental Finding: Often found incidentally on chest X-ray as a coin lesion.

  • Types:

    1. Chondromatous Hamartoma (more common)

      • Solitary, peripheral, spherical mass (2–5 cm)

      • Contains cartilage, fibrous and fat tissue, and bronchial epithelium

      • Usually asymptomatic

    2. Leiomyomatous Hamartoma

      • Multiple small nodules (1–2 mm), near pleura

      • Made of smooth muscle and bronchiolar structures


METASTATIC LUNG TUMOURS

  • More common than primary lung cancers

  • Spread by:

    • Blood (hematogenous) → most common

    • Lymphatics

    • Direct extension

  • Common appearance: Peripheral, multiple/single nodular masses (“cannon-ball secondaries”).

  • Primary sites:

    • Carcinomas: bowel, breast, thyroid, kidney, pancreas, liver, lung

    • Others: osteogenic sarcoma, neuroblastoma, Wilms' tumour, melanoma, lymphomas, leukaemias


PLEURA

NORMAL STRUCTURE

  • Visceral pleura: Covers lungs and fissures

  • Parietal pleura: Lines chest wall, mediastinum, diaphragm

  • Pleural cavity: Thin space with <15 mL of clear fluid

  • Lining: Single layer of mesothelial cells with connective tissue beneath


PLEURAL INFLAMMATIONS (PLEURITIS / PLEURISY)

1. Serous, Fibrinous & Serofibrinous Pleuritis

  • Causes: TB, pneumonia, lung abscess, infarcts, autoimmune diseases (RA, SLE), uraemia, radiation

  • Symptoms: Chest pain, pleural friction rub

  • Course: Usually resolves; repeated attacks → fibrosis and adhesions

2. Suppurative Pleuritis (Empyema Thoracis)

  • Purulent infection of pleural cavity (pus)

  • Causes: Spread from lung infections, abscesses, trauma

  • Complications: Fibrosis, adhesion, respiratory difficulty, calcification

3. Haemorrhagic Pleuritis

  • Inflammatory bloody effusion, different from haemothorax

  • Causes: Metastases to pleura, bleeding disorders, rickettsial diseases


NON-INFLAMMATORY PLEURAL EFFUSIONS

1. Hydrothorax

  • Clear, serous fluid (transudate) in pleural cavity

  • Causes: CHF (most common), renal/liver failure, Meig’s syndrome, tumors

  • Findings: Often bilateral; large effusion may shift trachea, cause dyspnoea

2. Haemothorax

  • Pure blood in pleural cavity

  • Causes: Trauma, ruptured aortic aneurysm

  • Complication: Clotting → fibrosis if not drained promptly

3. Chylothorax

  • Milky lymphatic fluid accumulation

  • Causes: Thoracic duct rupture or obstruction (e.g. lymphomas)

  • Usually on left side


PNEUMOTHORAX

  • Air in pleural cavity → lung collapse

Types:

  1. Spontaneous

    • Common with emphysema, asthma, TB, bronchiectasis

    • In young: idiopathic rupture of subpleural blebs

  2. Traumatic

    • Due to chest injury, surgery, ruptured esophagus/stomach

  3. Therapeutic

    • Previously used for TB treatment by inducing lung collapse

Complication:

  • Tension Pneumothorax: One-way air entry, no exit
    → Mediastinal shift, respiratory distress
    → Needs emergency decompression


TUMOURS OF PLEURA

1. Primary Pleural Tumour: Mesothelioma

A. Benign (Solitary) Mesothelioma
  • Also called pleural fibroma

  • No asbestos link

  • Small (<3 cm), firm, whorled fibrous mass

  • Microscopy: Dense collagen with fibroblasts; rarely lined by mesothelium

  • Asymptomatic, sometimes causes hypoglycemia or osteoarthropathy

  • Prognosis: Curable with removal

B. Malignant (Diffuse) Mesothelioma
  • Highly aggressive, poor prognosis

  • Strongly associated with asbestos exposure (esp. crocidolite)

  • Latency: Appears 20–40 years after exposure

  • No synergistic effect with smoking (unlike bronchogenic carcinoma)

  • Other cause: SV40 virus (implicated)

  • Gross: Thick, white, fleshy coat over pleural surfaces

  • Histologic Types:

    • Epithelial: Adenocarcinoma-like tubular/papillary pattern

    • Sarcomatoid: Spindle-shaped cells, fibrosarcoma-like

    • Biphasic: Mixture of both

  • Clinical features: Chest pain, dyspnoea, pleural effusion

  • Spread: Lung invasion, lymphatics, liver metastasis

  • Prognosis: 50% die within 1 year


2. Secondary Pleural Tumours

  • More common than primary

  • Causes: Lung, breast (via lymphatics), ovary (haematogenous)

  • Appearance: Multiple nodules over pleura

Comments

Popular posts from this blog

Blood Vessels

Lymphoid System

Heart